Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke

Stroke

Volumn 33, Issue 3, 2002, Pages 670-674

  Toth, Cory ^a   Voll, Chris ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Heparin; Ischemic attack, transient; Nomogram; Stroke

Indexed keywords

HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BODY WEIGHT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEALTH CARE COST; HOSPITAL PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRANSIENT ISCHEMIC ATTACK; VALIDATION PROCESS;

AGED; ANTICOAGULANTS; BODY WEIGHT; CEREBROVASCULAR ACCIDENT; DECISION SUPPORT TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; ISCHEMIC ATTACK, TRANSIENT; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0036195257     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs0302.104168     Document Type: Article

References (17)

1. Heparin: Mechanism of action: Pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
2. Pharmacokinetics, clinical indications, and adverse effects of heparin
3. Heparin
4. Optimal therapeutic level of heparin therapy in patients with venous thrombosis
5. Guide to anticoagulant therapy, part I: Heparin
6. Hemorrhagic complications of anticoagulant treatment
7. A standard heparin nomogram for the management of heparin therapy
8. The weight-based heparin-dosing nomogram compared with a standard care nomogram
9. How to improve heparin dosing by using a nomogram
10. How to optimize heparin anticoagulation
11. Cervicocranial arterial dissection
12. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
13. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study: HAEST Study Group: Heparin in Acute Embolic Stroke Trial
14. Low-molecular-weight heparin for the treatment of acute ischemic stroke
15. Low molecular weight heparinoid ORG 10172 (danaparoid) and outcome after ischemic stroke: A randomized controlled trial
16. Thrombosis of lienal vein and acute consumptive coagulopathy following warfarin administration in a patient with severe protein C deficiency
17. Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis